Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ACC 2019AUGUSTUS Backs Apixaban 'Double Therapy' in Most AF Post-ACS, PCIThe most safe and effective antithrombotic regimen may involve neither warfarin nor aspirin, suggested a trial that might allay bleeding-risk concerns in a tough-to-treat atrial fibrillation population.
Medscape Medical News, March 17, 2019
ACC 2019Apple Watch Helps Detect AF: Is This the Future? The first study of its kind involving more than 400,000 members of the general population used an Apple Watch to identify irregular pulse and received a mixed response from ACC delegates.
Medscape Medical News, March 16, 2019
Meeting Highlights At A Glance
Top News From ACC 2019: SlideshowStanding-ovation worthy research on transcatheter aortic valve replacement (TAVR) in low-surgical-risk patients featured prominently
at this year's scientific session.
Taking the Pulse of the Apple Heart StudyWhat did we really learn from the study using a smart watch and phone app to identify atrial fibrillation? New ways to conduct
research, but not much to advance practice, argues John Mandrola, MD.
A Sobering Breakthrough in AF CareFrequent alcohol drinkers with atrial fibrillation benefitted from abstinence in a novel randomized trial, which prompts the
question: Should temperance be prescribed before meds and procedures?
Boom: TAVR Low-Risk Trials Usher in a New Era in CardiologyThe results are impressive for transcatheter aortic valve replacement in low-surgical-risk patients, but longer-term data
on durability will be crucial, notes John Mandrola, MD.
Quick Thoughts on the Wrap-IT TrialAn antibiotic-impregnated envelope casing for cardiac implantable devices may lower the risk for infection, but is it enough
to justify the costs?
What's New and Useful in Hypertension From ACC.19Melissa Walton-Shirley's takeaways on hypertension management, a topic close to her heart, from the latest studies and expert
presentations at the 2019 American College of Cardiology Scientific Session.
Burnout: Is the Red Tide Finally Beginning to Turn?Burned out listening to burn-out talks? An intense session at ACC.19 left Melissa Walton-Shirley, MD, hopeful that some of
those words would finally turn into action.
Popular News from ACC 2018
ODYSSEY: Alirocumab Cuts CV Events, All-Cause Death Post-ACSFirst evidence of survival benefit with PCSK9 inhibitor alirocumab reignites the call for greater access to these expensive
drugs for patients not just with ACS but also with stable atherosclerotic CVD.
Medscape Medical News, Mar 10, 2018
VEST: No Sudden Death Benefit Early Post-MI From LifeVestBut defibrillators work by preventing sudden death, so it's a bit of a head-scratcher that all-cause mortality dropped instead
for people who used the wearable defibrillator for 90 days after their MI.
Medscape Medical News, Mar 10, 2018
Barbershop-Based Healthcare Cuts Hypertension in BlacksAn outreach program leveraging the community barbershop made impressive inroads combatting hypertension in black men, who
have the highest hypertension-related death rate in the United States.